Glivec (imatinib mesylate)/Litalir (hydroxyurea) plus initial radiotherapy after surgery in patients with newly diagnosed glioblastoma multiforme followed by Glivec and Litalir - A phase I/II safety evaluation study.
Phase of Trial: Phase II
Latest Information Update: 31 May 2011
At a glance
- Drugs Hydroxycarbamide; Imatinib
- Indications Glioblastoma
- Focus Adverse reactions
- 31 May 2011 New trial record